Zobrazeno 1 - 10
of 54
pro vyhledávání: '"S, Berioli"'
Autor:
Erich Bluhmki, Christopher P. Cannon, C. Michael Gibson, NL Fox, S Berioli, Frans Van de Werf, Eugene Braunwald, F Wang-Clow, Thierry Danays, David C. Stump
Publikováno v:
American Heart Journal. 141:33-40
TNK-tissue plasminogen activator (TNK-tPA) is a potent new thrombolytic agent for treatment of acute myocardial infarction. TNK-tPA was evaluated in 4214 patients in two dose-ranging trials (Thrombolysis in Myocardial Infarction [TIMI] 10B and Assess
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::10f2912815be3820ccffd4ce4debea18
https://doi.org/10.1067/mhj.2001.112092
https://doi.org/10.1067/mhj.2001.112092
Autor:
Sabina A. Murphy, C. Michael Gibson, A.A.Jennifer Adgey, NL Fox, Rafael F. Sequeira, Marc J. Schweiger, Gilles Grollier, W. Douglas Weaver, Christopher P. Cannon, Eugene Braunwald, S Berioli, Frans Van de Werf
Publikováno v:
The American Journal of Cardiology. 84:976-980
Fixed doses of thrombolytic agents are generally administered to patients of varying body weights, and the dose-response relation may be confounded by the variability in patient weight. We hypothesized that higher doses of TNK-tissue plasminogen acti
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::66b695eb16a28e9299dda4cf334ebf24
https://doi.org/10.1016/s0002-9149(99)00483-x
https://doi.org/10.1016/s0002-9149(99)00483-x
Autor:
NL Fox, Erich Bluhmki, Frans Van de Werf, Katrijn Houbracken, Eugene Braunwald, Christopher P. Cannon, F Wang-Clow, S Berioli, Anne Luyten, Carolyn H. McCabe, Hans Sarelin
Publikováno v:
American Heart Journal. 137:786-791
Background To evaluate the safety of several doses of a new thrombolytic, TNK tissue-plasminogen activator (tPA), given as a single bolus to patients with acute myocardial infarction. Methods and Results A total of 3235 patients were given TNK-tPA: 1
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::dea2b90dba9e7fa7c5b2420cc30d30f5
https://doi.org/10.1016/s0002-8703(99)70400-x
https://doi.org/10.1016/s0002-8703(99)70400-x
Autor:
D, FURBETTA, S, BERIOLI
Publikováno v:
Il Policlinico. Sezione pratica. 54(21)
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::7b284c8c23d707757d4a43d2ff60e126
https://pubmed.ncbi.nlm.nih.gov/20334295
https://pubmed.ncbi.nlm.nih.gov/20334295
Autor:
NL Fox, Xuri Li, Paul W. Armstrong, Hal V. Barron, Christopher B. Granger, F.W. Verheugt, Robert M. Califf, G I Barbash, Kenneth Pehrsson, S Berioli, F. Van de Werf, Amadeo Betriu, Jürgen Meyer
Publikováno v:
European Heart Journal, 22, 2253-61
European Heart Journal, 22, 24, pp. 2253-61
European Heart Journal, 22, 24, pp. 2253-61
Item does not contain fulltext BACKGROUND: Fibrinolytic therapy increases the risk of bleeding events. TNK-tPA (tenecteplase) is a variant of rt-PA with greater fibrin specificity and reduced plasma clearance that can be given as a single bolus. We c
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::a0ceb7e3fd302757802327920fbb371a
https://pubmed.ncbi.nlm.nih.gov/11728139
https://pubmed.ncbi.nlm.nih.gov/11728139
Publikováno v:
European urology. 40
Few epidemiological studies are available on Italian patients with lower urinary tract symptoms and their QoL. QUIBUS (QUality of life Investigated in BPH patients with Urinary Symptoms) is an observational longitudinal study aimed at evaluating symp
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::105a92a3ba147f1ec7f356d436f302b2
https://pubmed.ncbi.nlm.nih.gov/11598345
https://pubmed.ncbi.nlm.nih.gov/11598345
Autor:
F. Van de Werf, Thierry Danays, F Wang-Clow, NL Fox, Emmanuel Lesaffre, Erich Bluhmki, S Berioli
Publikováno v:
European heart journal. 22(11)
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::9bad8513a1fcfa8f91961cf0a2738da3
https://pubmed.ncbi.nlm.nih.gov/11428813
https://pubmed.ncbi.nlm.nih.gov/11428813
Autor:
C M, Gibson, C P, Cannon, S A, Murphy, A A, Adgey, M J, Schweiger, R F, Sequeira, G, Grollier, N L, Fox, S, Berioli, W D, Weaver, F, Van de Werf, E, Braunwald
Publikováno v:
The American journal of cardiology. 84(9)
Fixed doses of thrombolytic agents are generally administered to patients of varying body weights, and the dose-response relation may be confounded by the variability in patient weight. We hypothesized that higher doses of TNK-tissue plasminogen acti
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::d9bd4910231f23f374dad89d7981da40
https://pubmed.ncbi.nlm.nih.gov/10569649
https://pubmed.ncbi.nlm.nih.gov/10569649
Autor:
F, Van de Werf, C P, Cannon, A, Luyten, K, Houbracken, C H, McCabe, S, Berioli, E, Bluhmki, H, Sarelin, F, Wang-Clow, N L, Fox, E, Braunwald
Publikováno v:
American heart journal. 137(5)
To evaluate the safety of several doses of a new thrombolytic, TNK tissue-plasminogen activator (tPA), given as a single bolus to patients with acute myocardial infarction.A total of 3235 patients were given TNK-tPA: 1705 received 30 mg, 1457 receive
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::f60b9dfd7f5d17f056284dc201f51f74
https://pubmed.ncbi.nlm.nih.gov/10220625
https://pubmed.ncbi.nlm.nih.gov/10220625
Publikováno v:
Cardiologia (Rome, Italy). 35(4)
Recent pharmacological studies confirmed the role of hypercholesterolemia in the pathogenesis of coronary atherosclerosis. A 10% reduction in cholesterol levels can reduce the risk of coronary heart disease by 15%. However many hypercholesterolemic p
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::0a7c6755608b58c8dd099d04b7f47165
https://pubmed.ncbi.nlm.nih.gov/2245435
https://pubmed.ncbi.nlm.nih.gov/2245435